Garcia-Ortega Dorian Y
Skin, Soft Tissue and Bone Tumors Department, National Cancer Institute (Mexico), Mexico City, Mexico.
Front Oncol. 2024 Oct 7;14:1432900. doi: 10.3389/fonc.2024.1432900. eCollection 2024.
Retroperitoneal sarcoma (RPS) represents a rare and heterogeneous group of malignancies, posing significant challenges in evaluation and management. Surgery, the cornerstone of RPS treatment, critically depends on complete resection for a favorable prognosis. The extent of resection is a crucial determinant of local control and survival. This review delves into the evolution of multidisciplinary management of localized RPS, highlighting the imperative to adapt surgical strategies to tumor histology, location, and patient functional status. We explore the principles of compartmental surgery-an extended first-line approach that involves resecting adjacent viscera for wide negative margins-and its effectiveness across different histological subtypes of RPS and more limited resections for other types. Particular emphasis is placed on the heterogeneity of the disease, as various histological subtypes exhibit distinct biological behaviors. This necessitates a shift away from a one-size-fits-all treatment approach. The review analyzes the role of different surgical strategies, focusing on histological type and location. Additionally, the potential benefits of (neo)adjuvant treatments, such as radiotherapy and chemotherapy, are examined, recognizing their specific histological indications and limitations. This comprehensive review consolidates recent data on surgical strategies and complementary therapies, advocating for a personalized approach tailored to histology. As understanding of the molecular and genetic underpinnings of RPS continues to evolve, so will strategies for its effective management, underscoring the need for global collaboration among specialists in this field to enhance our collective knowledge and treatment methodologies.
腹膜后肉瘤(RPS)是一组罕见且异质性的恶性肿瘤,在评估和管理方面带来了重大挑战。手术是RPS治疗的基石,对良好预后至关重要,完全切除是关键。切除范围是局部控制和生存的关键决定因素。本综述深入探讨了局限性RPS多学科管理的演变,强调了根据肿瘤组织学、位置和患者功能状态调整手术策略的必要性。我们探讨了分区手术的原则——一种扩展的一线方法,即切除相邻脏器以获得广泛的阴性切缘——以及其在不同组织学亚型的RPS中的有效性,以及对其他类型进行更有限切除的情况。特别强调了该疾病的异质性,因为各种组织学亚型表现出不同的生物学行为。这就需要摒弃一刀切的治疗方法。本综述分析了不同手术策略的作用,重点关注组织学类型和位置。此外,还研究了(新)辅助治疗(如放疗和化疗)的潜在益处,认识到它们特定的组织学适应症和局限性。这一全面综述整合了关于手术策略和辅助治疗的最新数据,倡导根据组织学制定个性化方法。随着对RPS分子和遗传基础的理解不断发展,其有效管理策略也将不断演变,这凸显了该领域专家开展全球合作以增进我们的集体知识和治疗方法的必要性。